MIT’s Love Lab developing a Covid-19 vaccine to potentially reach billions
Manufacturability is key to producing a widely available, affordable vaccine.
MIT-affiliated companies take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
Storing medical information below the skin’s surface
Specialized invisible dye, delivered along with a vaccine, could enable “on-patient” storage of vaccination history to save lives in regions where paper or digital records aren’t available.
MIT Medical shatters previous one-day flu-shot record
During the community flu clinic on Oct. 3, at least 9,378 people on campus had received vaccinations — an average of one shot every 3.8 seconds.
Delivery system can make RNA vaccines more powerful
Vaccines packaged in novel nanoparticles could offer a new way to fight cancer and infectious diseases.
Structure of T cell epitopes a decisive factor in natural HIV control, study finds
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
Squeezing cells to cure diseases
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.
A single-injection vaccine for the polio virus
Nanoparticles could offer a new way to help eradicate the disease worldwide.
MIT Medical shatters one-day flu shot record
This year’s clinic lived up to its reputation as one of the most efficient operations at MIT.
Deploying therapeutic payloads to cells
Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.
Progress toward a Zika vaccine
Researchers program RNA nanoparticles that could protect against the virus.
MIT undertakes Grand Challenge for innovation in global vaccine manufacturing
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Nearly 5,000 shots given at first campus flu clinic of 2016
Second clinic to take place Thursday, Oct. 20, at the Stratton Student Center.
Benefiting human health through engineering
PhD student Anasuya Mandal’s microneedle device could painlessly monitor the immune system.
Engineers design programmable RNA vaccines
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.